Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-09 4:10 pm Purchase |
2025-06-06 | 13G | IDEAYA Biosciences, Inc. IDYA |
Point72 Asset Management, L.P. | 4,412,432 5.000% |
4,342,982 (+6253.39%) |
Filing History |
| 2025-06-04 4:32 pm Purchase |
2025-05-29 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Point72 Asset Management, L.P. | 4,401,659 5.100% |
4,401,659 (New Position) |
Filing History |
| 2025-05-21 4:52 pm Purchase |
2025-05-20 | 13G | Cybin Inc. CYBN |
Point72 Asset Management, L.P. | 1,326,185 6.300% |
1,033,788 (+353.56%) |
Filing History |
| 2025-05-19 4:10 pm Purchase |
2025-05-16 | 13G | Teladoc Health, Inc. TDOC |
Point72 Asset Management, L.P. | 8,826,350 5.000% |
1,358,956 (+18.20%) |
Filing History |
| 2025-05-15 4:35 pm Sale |
2025-03-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Point72 Asset Management, L.P. | 1,212,728 5.800% |
-35,508 (-2.84%) |
Filing History |
| 2025-05-15 4:34 pm Sale |
2025-03-31 | 13G | Bicycle Therapeutics plc BCYC |
Point72 Asset Management, L.P. | 3,739,318 7.800% |
-490,984 (-11.61%) |
Filing History |
| 2025-05-15 4:33 pm Purchase |
2025-03-31 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 2,368,370 7.700% |
676,998 (+40.03%) |
Filing History |
| 2025-05-15 4:32 pm Purchase |
2025-03-31 | 13G | PepGen Inc. PEPG |
Point72 Asset Management, L.P. | 2,675,937 8.200% |
804,742 (+43.01%) |
Filing History |
| 2025-05-15 4:31 pm Purchase |
2025-03-31 | 13G | Mobileye Global Inc. MBLY |
Point72 Asset Management, L.P. | 6,246,097 6.200% |
1,193,774 (+23.63%) |
Filing History |
| 2025-05-15 4:30 pm Sale |
2025-03-31 | 13G | Sphere Entertainment Co. SPHR |
Point72 Asset Management, L.P. | 1,535,450 5.300% |
-569,841 (-27.07%) |
Filing History |
| 2025-05-15 4:28 pm Sale |
2025-03-31 | 13G | Sagimet Biosciences Inc. SGMT |
Point72 Asset Management, L.P. | 1,755,143 5.700% |
-712,985 (-28.89%) |
Filing History |
| 2025-05-15 4:27 pm Purchase |
2025-03-31 | 13G | Tower Semiconductor Ltd. TSEM |
Point72 Asset Management, L.P. | 7,653,786 6.900% |
2,037,579 (+36.28%) |
Filing History |
| 2025-05-15 4:26 pm Sale |
2025-03-31 | 13G | Alto Neuroscience, Inc. ANRO |
Point72 Asset Management, L.P. | 1,907,831 7.000% |
-452,100 (-19.16%) |
Filing History |
| 2025-05-15 3:58 pm Sale |
2025-03-31 | 13G | Teladoc Health, Inc. TDOC |
Point72 Asset Management, L.P. | 7,467,394 4.300% |
-4,999,077 (-40.10%) |
Filing History |
| 2025-05-15 3:57 pm Sale |
2025-03-31 | 13G | Array Technologies, Inc. ARRY |
Point72 Asset Management, L.P. | 3,054,653 2.000% |
-4,559,334 (-59.88%) |
Filing History |
| 2025-05-15 3:55 pm Sale |
2025-03-31 | 13G | aTyr Pharma, Inc. ATYR |
Point72 Asset Management, L.P. | 2,845,354 3.200% |
-2,194,492 (-43.54%) |
Filing History |
| 2025-05-15 3:54 pm Sale |
2025-03-31 | 13G | Dyne Therapeutics, Inc. DYN |
Point72 Asset Management, L.P. | 1,669,342 1.500% |
-3,527,255 (-67.88%) |
Filing History |
| 2025-05-15 3:53 pm Sale |
2025-03-31 | 13G | Whitehawk Therapeutics Inc WHWK |
Point72 Asset Management, L.P. | 5,087 0.000% |
-1,465,224 (-99.65%) |
Filing History |
| 2025-05-15 3:52 pm Sale |
2025-03-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
Point72 Asset Management, L.P. | 1,048,343 1.200% |
-3,771,990 (-78.25%) |
Filing History |
| 2025-05-15 3:51 pm Sale |
2025-03-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Point72 Asset Management, L.P. | 1,543,931 2.300% |
-1,681,319 (-52.13%) |
Filing History |